Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation From HLA Matched Unrelated Donors for Treatment of Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission - A Multicenter Trial.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ciclosporin; Fludarabine; Mycophenolate mofetil
- Indications Graft-versus-host disease; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 07 Dec 2012 Biomarkers information updated
- 06 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Apr 2012 Planned end date (Aug 2006) added as reported by ClinicalTrials.gov.